- Home
- KLRS vs OPHC Comparison
KLRS vs OPHC Comparison
Compare KLRS & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KLRS | OPHC |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 110.1M |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | KLRS | OPHC |
|---|---|---|
| Price | $3.94 | $8.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.00 | $6.50 |
| AVG Volume (30 Days) | 53.3K | ★ 183.5K |
| Earning Date | 05-13-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.70 | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | ★ $165,000.00 | N/A |
| Revenue This Year | N/A | $17,095.98 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $3.91 |
| 52 Week High | $11.88 | $10.68 |
Technical Indicators
Market Signals| Indicator | KLRS | OPHC |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 54.05 |
| Support Level | $3.92 | $8.49 |
| Resistance Level | $4.37 | $9.24 |
| Average True Range (ATR) | 0.25 | 0.56 |
| MACD | 0.00 | -0.19 |
| Stochastic Oscillator | 22.00 | 17.35 |
Price Performance
Historical ComparisonAbout KLRS Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. The services provided by the bank include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, borrowings, repayment of loans, money market deposit accounts, debit cards, automated teller machines, and other bank related services.